KCM
UROV

Kornitzer Capital Management’s Urovant Sciences Ltd. UROV Stock Holding History

Kornitzer Capital Management’s Portfolio UROV Stock Details UROV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-51,100
Closed -$477K – 510
2020
Q3 		$477K Hold
51,100
– – 0.01% 459
2020
Q2 		$503K Hold
51,100
– – 0.01% 458
2020
Q1 		$471K Hold
51,100
– – 0.01% 447
2019
Q4 		$793K Hold
51,100
– – 0.01% 437
2019
Q3 		$484K Hold
51,100
– – 0.01% 453
2019
Q2 		$404K Hold
51,100
– – 0.01% 466
2019
Q1 		$514K Hold
51,100
– – 0.01% 435
2018
Q4 		$337K Sell
51,100
-23,900
-32% -$217K 0.01% 452
2018
Q3 		$900K Buy
+75,000
New +$887K 0.01% 400

Other funds holding UROV

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.02% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
OCM
Orchard Capital Management Chicago, Illinois $95.9M AUM 45.49% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

Kornitzer Capital Management's UROV Position: Q4 2020 in Review

Kornitzer Capital Management sold out of Urovant Sciences Ltd. (UROV) in Q4 2020, closing a stake of 51,100 shares — an estimated $477K sold.

Kornitzer Capital Management first reported a position in UROV in Q3 2018 and held it in 9 quarters. The position peaked at $900K in Q3 2018. 41 funds tracked by Wall St. Rank hold UROV as of Q4 2020.

  • Kornitzer Capital Management reported no remaining Urovant Sciences Ltd. position as of Q4 2020 after selling out during the quarter.
  • Kornitzer Capital Management sold 51,100 Urovant Sciences Ltd. shares in Q4 2020, an estimated $477K.
  • Kornitzer Capital Management first reported a position in Urovant Sciences Ltd. in Q3 2018 and held it in 9 quarters.
  • Kornitzer Capital Management's Urovant Sciences Ltd. position peaked at $900K in Q3 2018.
  • 41 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q4 2020.

Based on Kornitzer Capital Management's 13F filing for Q4 2020, filed 29 Jan 2021.